Widely acclaimed as a breakthrough in reducing maternal mortality ratios, tranexamic acid offers a glimmer of hope to the millions of women around the world at risk of dying during childbirth every year. This new drug presents clear evidence that we have the knowledge and technology to save lives: the challenge now is its distribution and effective implementation in regions at greatest risk.